Researchers at Medimmune Inc. have reported that a bispecific antibody, MEDI3902, could protect mice from infection with Pseudomonas aeruginosa, a bacterium that causes hospital-acquired pneumonia and is responsible for about 10 percent of all hospital-acquired infections in the U.S.